Calls
1
u/fousekis7
Reddit r/pennystocks
Win Rate
0.0%
return
-71.9%
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
Long
Jan 08
$2.10
-71.9%
Author is long-biased on Fractyl Health ($GUTS), a biotech whose Revita one-off procedure may let patients stopping GLP-1s such as Mounjaro or Wegovy maintain weight loss. The mechanism is a large obesity/weight-loss market and a simple procedure that could appeal to patients, practitioners, insurers and regulators, especially after an Oxford study cited by the author said stopping GLP-1s leads to weight regain. Catalysts include 6-month randomized data at the end of January and seven back-to-back 2026 events culminating in an FDA premarket approval filing; the author also notes cash runway into early 2027 and a new CFO hire.
GLP-1 / Obesity
Showing 1 of 1 calls · sorted by mentions
Choose a mentions count to open ticker posts.
u/fousekis7 has 1 trade ideas tracked on Buzzberg across 1 tickers since January 2026. Most covered: GUTS.
Historical call returns are modeled from recorded ideas and stored prices, not actual brokerage portfolio returns. Check the evaluated call set and horizon; past results do not establish future prediction accuracy. Explore our data and methodology
